The esteemed ESMO Award was established in 1985 to annually recognise an ESMO member who has made an outstanding contribution to the development of medical oncology and who recognises the importance of promoting medical oncology as a speciality within the international community.
All awardees have made an outstanding contribution to the development of medical oncology and recognise the importance of promoting medical oncology as a speciality within the international community.
Candidates for the award will be considered by the ESMO Fellowship and Award Committee of renowned cancer leaders. After careful deliberations by the committee, its recommendations will be forwarded to the ESMO Executive Board for final consideration and selection.
The choice of the award winner will be made on the basis of the candidate's scientific accomplishments. No regard will be given to race, gender, and nationality, religious or political views.
The award consists of a statuette, certificate, free registration, free accommodation and reimbursement of travel expenses to the Congress where the ceremony takes place.
The 2012 ESMO Award winner is Prof. Ian Tannock, University of Toronto, Canada.
ESMO is a truly international and intercontinental society, but I am particularly honoured to be the first oncologist not to be based in Europe to receive this award. Part of it should be given to the many international fellows who have collaborated with me - their ideas and enthusiasm have sustained my career and my greatest reward is observing their success.
Awardees of the ESMO Award
2012 - Ian Tannock, Canada
The 2012 ESMO Award has been bestowed to Professor Ian Tannock for his work on clinical trials for men with metastatic prostate cancer and laboratory-based research on the micro-environment of solid tumours, their resistance to drugs and methods to overcome it. The Award recognizes his tremendous contributions in improving methodology for undertaking clinical trials with emphasis on endpoints of clinical benefit and, at a laboratory level, unmasking aspects of solid tumour biology as well as improving outcomes of treatment with chemotherapy.
Based at the University of Toronto, Canada, where he is Professor of Medicine and Medical Biophysics, Prof. Tannock has led and helped to design trials that led to the identification of optimal chemotherapy for men with metastatic castration-resistant prostate cancer.
2011 - Johann de Bono, United Kingdom
The 2011 ESMO Award has been granted to Professor de Bono, who has dedicated his life to oncology translational and clinical research, innovative treatment, education and development of international guidelines for prostate cancer management. Prof. de Bono is internationally recognised for the advancement of prostate cancer management and renowned for his innovative ideas in translational and clinical research in early drug development. He is highly appreciated for his rigorous methodology and mentorship of many young oncologists and he has been a key contributor in the success of the joint ECCO–AACR–EORTC–ESMO Workshop on 'Methods in Clinical Cancer Research' held in Flims. Prof. de Bono deserves this award for his exceptional work in the development of a number of new innovative compounds for several new indications in oncology and his exceptional contribution to the development of new drugs in prostate cancer, particularly through excellence in translational research and study design. One of the recently approved drugs from this development pipeline is abiraterone acetate, intended for the treatment of aggressive and previously drug resistant prostate cancer. This is a major breakthrough advance in the treatment of medically resistant prostate cancer.
2010 - Alberto Costa, Italy
The 2010 ESMO Award recipient is Dr. Alberto Costa, who has dedicated his life to oncology research, treatment, education, development of international guidelines for breast cancer management and novel surgical treatments. In addition to impressive scientific contributions, he was also fundamental in establishing the distinguished European School of Oncology. Dr. Costa is internationally recognised for the advancement of breast cancer management and renowned for his innovative ideas in scientific communication and educational development.
Previous recipients of the ESMO Award
- 2009 - E.G. Elisabeth de Vries, The Netherlands
- 2008 - J.P. Armand, France
- 2007 - J.B. Vermorken, Belgium
- 2006 - D.J. Kerr, United Kingdom
- 2005 - J. Baselga, Spain
- 2004 - A.T. van Oosterom, Belgium
- 2002 - M. Schneider, France
- 2000 - R. Souhami, United Kingdom
- 1998 - D.J.Th. Wagener, The Netherlands
- 1997 - M. Piccart, Belgium
- 1995 - S.B. Kaye, United Kingdom
- 1993 - P. Alberto, Switzerland
- 1991 - F. Cavalli, Switzerland
- 1989 - G. Bonadonna, Italy
- 1987 - H.H. Hansen, Denmark
- 1985 - H.M. Pinedo, The Netherlands